Adenosine A2a Receptor ELISA Kit

Catalog No. ABIN2944920

Product Details Adenosine A2a Receptor ELISA Kit

Target: Adenosine A2a Receptor (ADORA2A)

Reactivity: Rat

Detection Method: Colorimetric

Method Type: Sandwich ELISA

Detection Range: 0.156 ng/mL - 10 ng/mL

Minimum Detection Limit: 0.156 ng/mL

Application: ELISA

Purpose: Rat Adenosine A2a Receptor ELISA Kit is an ELISA Kit against Adenosine A2a Receptor.

Sample Type: Plasma, Serum

Analytical Method: Quantitative

Sensitivity: 0.1 ng/mL

Application Details

Application Notes:

Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.

Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.

Standard Form: Lyophilized

Plate: Pre-coated

Restrictions: For Research Use only

Handling

Storage: 4 °C/-20 °C

Storage Comment: Upon receipt, store the kit according to the storage instruction in the kit's manual.

Expiry Date: 6 months

Target Details for Adenosine A2a Receptor

Target: Adenosine A2a Receptor (ADORA2A)

Alternative Name: Adenosine A2a Receptor (ADORA2A Products)

Synonyms: ADORA2A ELISA Kit, adora2a.1 ELISA Kit, zgc:194773 ELISA Kit, A2aR ELISA Kit, ADORA2 ELISA Kit, RDC8 ELISA Kit, A2AAR ELISA Kit, AA2AR ELISA Kit, A2ar ELISA Kit, ADENO ELISA Kit, Adora2l1 ELISA Kit, adora2a.2 ELISA Kit, zgc:193802 ELISA Kit, zgc:193822 ELISA Kit, adenosine A2a receptor ELISA Kit, adenosine A2a receptor a ELISA Kit, adenosine A2a receptor L homeolog ELISA Kit, adenosine A2a receptor b ELISA Kit, ADORA2A ELISA Kit, Adora2a ELISA Kit, adora2aa ELISA Kit, adora2a.L ELISA Kit, adora2a ELISA Kit, adora2ab ELISA Kit

Pathways: Neurotrophin Signaling Pathway, cAMP Metabolic Process, Synaptic Membrane, Feeding Behaviour, Cancer Immune Checkpoints